Literature DB >> 15082609

Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

J Dent1, D Armstrong, B Delaney, P Moayyedi, N J Talley, N Vakil.   

Abstract

There has been no published indepth systematic evaluation of the best approaches to symptom evaluation in gastro-oesophageal reflux disease (GORD). A two day international multidisciplinary workshop was therefore held in Marrakech, Morocco, in September 2002 to address these issues. The aim of the workshop was to critically review the data regarding the reliability, processes, and priorities for symptom evaluation in GORD patients. The workshop was designed to give outputs that could be readily reported and to arrive at specific recommendations on best practice in symptom evaluation in reflux disease.

Entities:  

Mesh:

Year:  2004        PMID: 15082609      PMCID: PMC1867782          DOI: 10.1136/gut.2003.034272

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  115 in total

1.  Are needs and satisfaction of care associated with quality of life? An epidemiological survey among the severely mentally ill in the Netherlands.

Authors:  D Wiersma; J van Busschbach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001-10       Impact factor: 5.270

2.  Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.

Authors:  S D Mathias; H H Colwell; D P Miller; D J Pasta; J M Henning; J J Ofman
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s.

Authors:  Bas P L Wijnhoven; Marieke W J Louwman; Hugo W Tilanus; Jan-Willem W Coebergh
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 2.566

4.  Counting cancers at the junction - a problem of routine statistics.

Authors:  David Forman
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 2.566

5.  Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication.

Authors:  Reginald V N Lord; Anna Kaminski; Stefan Oberg; David J Bowrey; Jeffrey A Hagen; Steven R DeMeester; Lelan F Sillin; Jeffrey H Peters; Peter F Crookes; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

6.  Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.

Authors:  D Armstrong; P Paré; D Pericak; M Pyzyk
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

7.  Barrett's esophagus: prevalence in symptomatic relatives.

Authors:  Yvonne Romero; Alan J Cameron; Daniel J Schaid; Shannon K McDonnell; Lawrence J Burgart; Cyndy L Hardtke; Joseph A Murray; G Richard Locke
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

8.  Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Authors:  Donald O Castell; Peter J Kahrilas; Joel E Richter; Nimish B Vakil; David A Johnson; Seth Zuckerman; Wendy Skammer; Jeffrey G Levine
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

9.  Long-term results of antireflux surgery indicate the need for a randomized clinical trial.

Authors:  R Sandbu; H Khamis; S Gustavsson; U Haglund
Journal:  Br J Surg       Date:  2002-02       Impact factor: 6.939

10.  Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes.

Authors:  W Ken Redekop; Marc A Koopmanschap; Ronald P Stolk; Guy E H M Rutten; Bruce H R Wolffenbuttel; Louis W Niessen
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

View more
  31 in total

Review 1.  Functional heartburn: definition and management strategies.

Authors:  Frank Zerbib; Stanislas Bruley des Varannes; Mireille Simon; Jean Paul Galmiche
Journal:  Curr Gastroenterol Rep       Date:  2012-06

Review 2.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 3.  Enhanced endoscopic imaging and gastroesophageal reflux disease.

Authors:  Rupa Banerjee; D Nageshwar Reddy
Journal:  Indian J Gastroenterol       Date:  2011-10-19

4.  Air column in esophagus and symptoms of gastroesophageal reflux disease.

Authors:  Alijavad Moosavi; Hanieh Raji; Mojtaba Teimoori; Shadi Ghourchian
Journal:  BMC Med Imaging       Date:  2012-01-25       Impact factor: 1.930

Review 5.  Treatment of uncomplicated reflux disease.

Authors:  Joachim Labenz; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

6.  Gastro-oesophageal reflux disease: a re-appraisal.

Authors:  Roger Jones
Journal:  Br J Gen Pract       Date:  2006-10       Impact factor: 5.386

Review 7.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

Review 8.  Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus.

Authors:  Mitchell M Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

9.  Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study.

Authors:  Fabio Pace; Gabriele Riegler; Annalisa de Leone; Patrizia Dominici; Enzo Grossi
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.